EUVIMEDEUVIMED entdecken
Crossref

Integrated Multi‐Omics and Experimental Validation Unveil the GZMK/NF‐κB Axis Driving Inflammation and Fibroblast Proliferation in Rosacea: A Novel Drug Target Selection Strategy

Jing Wang iD, Lingbo Bi iD, Hanqing Zhao, Zining Xu, Zhou Zhuang, Kejun Chen, Hongfei Ouyang, Jingkai Xu, Yujun Sheng, Ziyi Wang, Yong Cui iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202502071r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Jing Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, China-Japan Friendship Hospital, Beijing, China. Hauptthemen laut MEDLINE: Rosacea, NF-kappa B, Cell Proliferation, Inflammation. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Ministry of Health of China | CJFH | China-Japan Friendship Hospital Youth Science and Technology Excellence Project, Outstanding Youth Project of Natural Science Foundation of Anhui Province, MOST | National Key Research and Development Program of China (NKPs).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of rosacea is high, while the drug options remain limited. Mendelian randomization (MR) is an effective way to prioritize plasma proteins as novel drug targets based on their causal effects on rosacea. The plasma proteins were categorized into different levels of drug targets by the MR and Bayesian colocalization analysis. Their genetic and protein expression was investigated using an RNA sequencing dataset and experiments in vitro and in vivo. MR and colocalization identified Granzyme K (GZMK) as a drug target, whose expression increased in the affected samples. A novel mouse model of rosacea was established by GZMK, mimicking rosacea‐like symptoms both in vitro and in vivo. GZMK also promoted cell proliferation and inflammatory factors (including IL‐1β, IL‐6, and TNFα) production in fibroblasts through activating the NF‐κB pathway in vitro. Our research identified a novel protein involved in rosacea pathogenesis, elucidated the underlying mechanisms, and advanced the development of potential rosacea treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RosaceaNF-kappa BCell ProliferationInflammationFibroblastsGranzymesAnimalsMiceHumansDisease Models, AnimalSignal TransductionMice, Inbred C57BLMultiomics

Stichwörter der Autor:innen

Bayesian colocalizationNF‐κBgranzyme Kmendelian randomizationrosacea

Substanzen

NF-kappa BGranzymes

Autor:innen und Institutionen

  • Department of Dermatology, China-Japan Friendship Hospital, Beijing, China.
  • Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

ORCID-Profile: Jing Wang, Lingbo Bi, Yong Cui

Förderung

  • Ministry of Health of China | CJFH | China-Japan Friendship Hospital Youth Science and Technology Excellence Project
  • Outstanding Youth Project of Natural Science Foundation of Anhui Province
  • MOST | National Key Research and Development Program of China (NKPs)
  • MOST | National Natural Science Foundation of China (NSFC)
  • National High Level Hospital Clinical Research Funding
  • China-Japan Friendship Hospital Youth Science and Technology Excellence Project
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Wang, J., Bi, L., Zhao, H., Xu, Z., Zhuang, Z., Chen, K., Ouyang, H., Xu, J., Sheng, Y., Wang, Z., & Cui, Y. (2025). Integrated Multi‐Omics and Experimental Validation Unveil the GZMK/NF‐κB Axis Driving Inflammation and Fibroblast Proliferation in Rosacea: A Novel Drug Target Selection Strategy. The FASEB Journal. https://doi.org/10.1096/fj.202502071r

Vancouver

Wang J, Bi L, Zhao H, Xu Z, Zhuang Z, Chen K, et al. Integrated Multi‐Omics and Experimental Validation Unveil the GZMK/NF‐κB Axis Driving Inflammation and Fibroblast Proliferation in Rosacea: A Novel Drug Target Selection Strategy. The FASEB Journal. 2025. doi:10.1096/fj.202502071r

BibTeX
@article{Wang2025,
  author = {Wang, Jing and Bi, Lingbo and Zhao, Hanqing and Xu, Zining and Zhuang, Zhou and Chen, Kejun and Ouyang, Hongfei and Xu, Jingkai and Sheng, Yujun and Wang, Ziyi and Cui, Yong},
  title = {Integrated Multi‐Omics and Experimental Validation Unveil the GZMK/NF‐κB Axis Driving Inflammation and Fibroblast Proliferation in Rosacea: A Novel Drug Target Selection Strategy},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202502071r}
}
Kostenlos starten →